EDIL3 and DDX43 were the most significantly upregulated genes in patients with high metastatic burden, whereas the cancer-testis (CT) antigens, such as MAGEA1, were found to show reduced expression in these patients. This evidence concerns the gene MAGEA1 and cancer.